Patent holdings for IPC class A61K 31/445

Total number of patents in this class: 4516

10-year publication summary

274
275
270
246
283
275
271
226
272
216
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Amicus Therapeutics, Inc.
353
165
Merck Sharp & Dohme Corp.
2190
45
Pacira Pharmaceuticals, Inc.
116
43
Takeda Pharmaceutical Company Limited
2717
39
The Regents of the University of California
20289
38
Bristol-myers Squibb Company
4820
36
Janssen Pharmaceutica N.V.
3351
30
Merck Sharp & Dohme LLC
3737
30
Boehringer Ingelheim International GmbH
4635
28
ChemoCentryx, Inc.
378
28
Suven Life Sciences Limited
135
27
Novartis AG
10623
24
Centre National de La Recherche Scientifique
10693
22
Heron Therapeutics, Inc.
153
22
Theravance Biopharma R&D IP, LLC
453
21
H. Lundbeck A/S
1237
21
Corium, LLC
43
21
The Trustees of the University of Pennsylvania
4384
20
The General Hospital Corporation
4797
19
Selecta Biosciences, Inc.
190
19
Other owners 3818